Commission Directive 2007/6/EC of 14 February 2007 amending Council Directive 91/414/EEC to include metrafenone, Bacillus subtilis , spinosad and thiamethoxam as active substances (Text with EEA relevance )
Date: 2007-02-14
Institutions: European Commission
Subjects: exchange of information, marketing standard, pharmaceutical product, plant health control, plant health legislation, plant health product

15.2.2007

EN

Official Journal of the European Union

L 43/13

DIRECTIVES

COMMISSION DIRECTIVE 2007/6/EC

of 14 February 2007
amending Council Directive 91/414/EEC to include metrafenone, Bacillus subtilis, spinosad and
thiamethoxam as active substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Directive 91/414/EEC of 15 July 1991
concerning the placing of plant protection products on the
market (1), and in particular Article 6(1) thereof,

Whereas:

(1)

(2)

(3)

In accordance with Article 6(2) of Directive 91/414/EEC
United Kingdom received on 4 June 2002 an application
from BASF AG, Belgium for the inclusion of the active
substance metrafenone
to Directive
91/414/EEC. Commission Decision 2003/105/EC (2)
confirmed that the dossier was ‘complete’
in the sense
that it could be considered as satisfying, in principle, the
data and information requirements of Annexes II and III
to Directive 91/414/EEC.

in Annex

I

for

the inclusion of

In accordance with Article 6(2) of Directive 91/414/EEC
Germany received on 19 April 2000 an application from
AgraQuest
the active substance
Bacillus subtilis strain QST 713 (hereafter Bacillus subtilis)
in Annex I
to Directive 91/414/EEC. Commission
Decision 2001/6/EC (3) confirmed that the dossier was
‘complete’
in the sense that it could be considered as
and information
satisfying,
in principle,
to Directive
requirements of Annexes
91/414/EEC.

the data

and III

II

In accordance with Article 6(2) of Directive 91/414/EEC
the Netherlands received on 19 July 1999 an application
from Dow AgroSciences for the inclusion of the active
substance spinosad in Annex I to Directive 91/414/EEC.
Commission Decision 2000/210/EC (4) confirmed that

(4)

(5)

(6)

the dossier was ‘complete’ in the sense that it could be
considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

In accordance with Article 6(2) of Directive 91/414/EEC
Spain received on 17 March 1999 an application from
for the
Novartis Crop Protection AG (now Syngenta)
the active substance thiamethoxam in
inclusion of
91/414/EEC. Commission
Annex
Decision 2000/181/EC (5) confirmed that
the dossier
was ‘complete’ in the sense that it could be considered
the data and information
in principle,
as satisfying,
requirements of Annexes
to Directive
II
91/414/EEC.

to Directive

and III

I

For those active substances, the effects on human health
and the environment have been assessed, in accordance
with the provisions of Article 6(2) and (4) of Directive
91/414/EEC, for the uses proposed by the applicants. The
designated rapporteur Member States submitted draft
assessment
reports concerning the substances to the
European Food Safety Authority (EFSA) on 31 October
2003 (metrafenone) and to the Commission on 15 May
2001 (Bacillus subtilis), 5 March 2001 (spinosad) and 21
January 2002 (thiamethoxam) respectively.

report has been peer
For metrafone the assessment
reviewed by the Member States and the EFSA within its
Working Group Evaluation and presented to the
Commission on 18 January 2005 in the format of the
EFSA Scientific Report for metrafenone (6). This report
has been reviewed by the Member States and the
Commission within the Standing Committee on the
subtilis,
Food Chain and Animal Health. For Bacillus
spinosad
assessment
reports have been reviewed by the Member States and
the Commission within the Standing Committee on the
Food Chain and Animal Health. The review was finalised
on 14 July 2006 in the format of
the Commission
review reports for metrafenone, Bacillus subtilis, spinosad
and thiamethoxam.

thiamethoxam the

draft

and

(1) OJ L 230, 19.8.1991, p. 1. Directive as

last amended by
Commission Directive 2006/136/EC (OJ L 349, 12.12.2006, p. 42).

(2) OJ L 43, 18.2.2003, p. 45.
(3) OJ L 2, 5.1.2001, p. 25.
(4) OJ L 64, 11.3.2000, p. 24.

(5) OJ L 57, 2.3.2000, p. 35.
(6) EFSA Scientific Report (2006)58, 1-72, Conclusion regarding the peer
review of the pesticide risk assessment of the active substance metra-
fenone (finalised: 13 January 2006).

L 43/14

EN

Official Journal of the European Union

15.2.2007

(7)

the

products

protection

containing

It has appeared from the various examinations made that
active
plant
substances concerned may be expected to satisfy,
in
general, the requirements laid down in Article 5(1)(a)
in
and (b) and Article 5(3) of Directive 91/414/EEC,
particular with regard to the uses which were examined
and detailed in the Commission review report.
is
therefore appropriate to include metrafenone, Bacillus
subtilis, spinosad and thiamethoxam in Annex I to that
Directive, in order to ensure that in all Member States the
authorisations of plant protection products containing
these active substances may be granted in accordance
with the provisions of that Directive.

It

six months after

in Annex I, Member States

(8) Without prejudice to the obligations defined by Directive
91/414/EEC as a consequence of
including an active
substance
should be
allowed a period of
inclusion to
review existing provisional
authorisations of plant
containing metrafenone, Bacillus
protection products
subtilis, spinosad or thiamethoxam to ensure that
the
in
requirements laid down by Directive 91/414/EEC,
particular in its Article 13 and the relevant conditions
set out in Annex I, are satisfied. Member States should
transform existing provisional authorisations into full
authorisations,
amend them or withdraw them in
Directive
accordance
91/414/EEC. By derogation from the above deadline, a
longer period should be provided for the submission and
assessment of the complete Annex III dossier of each
for each intended use in
plant protection product
accordance with the uniform principles laid down in
Directive 91/414/EEC.

provisions

with

the

of

(9)

(10)

is

It
therefore
91/414/EEC accordingly.

appropriate

to

amend Directive

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Directive are in
Standing
the

opinion

the

of

HAS ADOPTED THIS DIRECTIVE:

Article 1

Annex I to Directive 91/414/EEC is amended as set out in the
Annex to this Directive.

communicate to the Commission the text of those provisions
and a correlation table between those provisions and this
Directive.

They shall apply those provisions from 1 August 2007.

When Member States adopt those provisions, they shall contain
a reference to this Directive or shall be accompanied by such a
reference on the occasion of their official publication. Member
States shall determine how such reference is to be made.

2. Member States shall communicate to the Commission the
text of the main provisions of national law which they adopt in
the field covered by this Directive.

Article 3

shall

States

1. Member
in accordance with Directive
91/414/EEC, where necessary, amend or withdraw existing
authorisations for plant protection products containing metra-
fenone, Bacillus subtilis, spinosad or thiamethoxam as active
substance by 31 July 2007. By that date, they shall in particular
verify that the conditions in Annex I to that Directive relating to
metrafenone, Bacillus subtilis, spinosad or thiamethoxam, respec-
tively, are met, with the exception of those identified in part B
of
the
the entry concerning the active substance, and that
holder of the authorisation has, or has access to, a dossier
satisfying the requirements of Annex II to that Directive in
accordance with the conditions of Article 13(2).

By way of derogation from paragraph 1,

2.
for each
authorised plant protection product containing metrafenone
or Bacillus subtilis or spinosad or thiamethoxam as either the
only active substance or as one of several active substances all
of which were listed in Annex I to Directive 91/414/EEC by 31
January 2007 at the latest, Member States shall re-evaluate the
product in accordance with the uniform principles provided for
in Annex VI to Directive 91/414/EEC, on the basis of a dossier
satisfying the requirements of Annex III to that Directive and
taking into account part B of the entry in Annex I to that
Directive concerning metrafenone, Bacillus subtilis, spinosad or
thiamethoxam. On the basis of
they shall
determine whether the product satisfies the conditions set out
in Article 4(1)(b), (c), (d) and (e) of Directive 91/414/EEC.

that evaluation,

Following that determination Member States shall:

Article 2

1. Member States shall adopt and publish by 31 July 2007 at
the latest the laws, regulations and administrative provisions
necessary to comply with this Directive. They shall forthwith

(a)

in the case of a product containing metrafenone or Bacillus
subtilis or spinosad or thiamethoxam as the only active
substance, where necessary, amend or withdraw the author-
isation by 31 July 2008 at the latest; or

15.2.2007

EN

Official Journal of the European Union

L 43/15

(b) in the case of a product containing metrafenone or Bacillus
subtilis or spinosad or thiamethoxam as one of several active
substances, where necessary,
amend or withdraw the
authorisation by 31 July 2008 or by the date fixed for
in the respective
such an amendment or withdrawal
Directive or Directives which added the relevant substance
or
to Directive 91/414/EEC,
whichever is the latest.

to Annex I

substances

Article 5

This Directive is addressed to the Member States.

Done at Brussels, 14 February 2007.

Article 4

This Directive shall enter into force on 1 February 2007.

For the Commission

Markos KYPRIANOU
Member of the Commission

L 43/16

EN

Official Journal of the European Union

15.2.2007

e
h
t

,
I

V

x
e
n
n
A

f
o

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,

s
i
l
i
t
b
u
s

s
u
l
l
i
c
a
B

s
e
l
p
i
c
n
i
r
p

m
r
o
f
i
n
u

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

B

T
R
A
P

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

6
0
0
2

y
l
u
J

4
1

n
o

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

.
t
n
u
o
c
c
a

e
h
t

,
I

V

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p

m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,
e
n
o
n
e
f
a
r
t
e
m

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

e
b

l
l
a
h
s

6
0
0
2

y
l
u
J

4
1

n

i

n
o

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

h
t
i

w

e
c
n
a
d
r
o
c
c
a

n

i

n
o
i
s
s
i

m
m
o
C

e
h
t

m
r
o
f
n

i

l
l
a
h
s

s
e
t
a
t
S

r
e
b
m
e
M

e
h
T

-
r
e
m
m
o
c

s
a

l
a
i
r
e
t
a
m

l
a
c
i
n
h
c
e
t

e
h
t

f
o

n
o
i
t
a
c
i
f
i
c
e
p
s

e
h
t

n
o

)

(

5
3
1

e
l
c
i
t
r
A

.

d
e
r
u
t
c
a
f
u
n
a
m

y
l
l
a
i
c

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

B

T
R
A
P

e
n
o
n
e
h
p
o
z
n
e
b
l
y
h
t
e
m
d
-
6

i

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

A

T
R
A
P

7
1
0
2

y
r
a
u
n
a
J

1
3

7
0
0
2

y
r
a
u
r
b
e
F

1

e
l
b
a
c
i
l

p
p
a

t
o
N

A

T
R
A
P

7
1
0
2

y
r
a
u
n
a
J

1
3

7
0
0
2

y
r
a
u
r
b
e
F

1

g
k
/
g
0
4
9
≥

,

′
2
-
y
x
o
h
t
e
m
a
r
t
e
t
-

,

,

,

′
6
4
3
2
-
o
m
o
r
b
-

′
3

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

n
o
i
s
u
l
c
n

i

f
o

n
o
i
t
a
r
i
p
x
E

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
1
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

6
-
3
0
-
9
9
8
0
2
2

:

o
N

S
A
C

2
5
7

:

o
N

C
A
P
I
C

e
n
o
n
e
f
a
r
t
e
M

9
3
1

‘

l
a
c
i
t
n
e
d

i

,

3
1
7

T
S
Q

n
i
a
r
t
S

3
1
7

Q
A

n
i
a
r
t
s

h
t
i

w

:

o
N

n
o
i
t
c
e
l
l

o
c

e
r
u
t
l
u
C

1
6
6
1
2
-

B

L
R
R
N

d
e
t
a
c
o

l
l
a

t
o
n

:

o
N

C
A
P
I
C

s
i
l
i
t
b
u
s

s
u
l
l
i
c
a
B

)

2
7
8
1

n
h
o
C

(

0
4
1

X
E
N
N
A

:

C
E
E
/
4
1
4
/
1
9

e
v
i
t
c
e
r
i

D

o
t

I

x
e
n
n
A

n

i

e
l
b
a
t

e
h
t

f
o

d
n
e

e
h
t

t
a

d
e
d
d
a

e
b

l
l
a
h
s

s
w
o
r

i

g
n
w
o

l
l

o
f

e
h
T

15.2.2007

EN

Official Journal of the European Union

L 43/17

e
h
t

,
I

V

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p

m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

,

,

,

,

,

,

,

,

9
7
6
b
5
a
5
a
3
3
2
-
l
y
h
t
e
-
9
-
)
y
x
o
l
y
s

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,

d
a
s
o
n
p
s

i

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

e
b

l
l
a
h
s

6
0
0
2

y
l
u
J

4
1

n

i

n
o

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

;
s

m

s
i
n
a
g
r
o

c
i
t
a
u
q
a

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

t
s
u
m

e
h
t

n
e
h
w

s

m
r
o
w
h
t
r
a
e

o
t

k
s
i
r

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

t
s
u
m

.
s
e
s
u
o
h
s
s
a
l
g

n

i

d
e
s
u

s
i

e
c
n
a
t
s
b
u
s

—

—

-
o
r
p
p
a

e
r
e
h
w

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

,

i

e
n
o
d
-
5
1
7
-
e
n
e
c
a
d
n
i
-
s
a
]
b
[
a
c
e
d
o
d
o
l
c

-
y
c
a
x
o
-
8
-
H
1
-
l
y
h
t
e
m
-
4
1
-
o
r
d
y
h
a
c
e
d

:

D

n
y
s
o
n
p
S

i

,

,

-
a
x
e
h
-
b
6
1
a
6
1
5
1
4
1
3
1
2
1
1
1
0
1

,

,

,

,

,

,

,

,

-
a
6
1
R
4
1
S
3
1
S
9
S
b
5
S
a
5
R
a
3
S
2

,

,

,

,

(

-
)
y
x
o
l
y
s
o
n
a
r
y
p
o
n
n
a
m
-
L
-

-
l
y
h
t
e
m

-

O

,

,

-
i
r
t
-
4
3
2
-
y
x
o
e
d
-
6
(
-
2
-
)
S
b
6
1
S

,

α

,

,

-
a
x
e
h
-
b
6
1
a
6
1
5
1
4
1
3
1
2
1
1
1
0
1
9

,

,

,

,

,

,

,

-
5
1
7
-
e
n
e
c
a
d
n
i
-
s
a
]
b
[
a
c
e
d
o
d
o
l
c
y
c
a
x
o

e
n
o
d

i

%
5
9
-
0
5

f
o

e
r
u
t
x
i
m

a

s
i

d
a
s
o
n
p
S

i

D

n
y
s
o
n
p
s

i

%
0
5
-
5

d
n
a

A

n
y
s
o
n
p
s

i

i

-
8
-
H
1
-
l
y
h
t
e
m
d
-
4
1
4
-
o
r
d
y
h
a
c
e
d

,

,

,

,

i

-
6
4
3
2
-
o
n
m
a
l
y
h
t
e
m
d
-
4
(
-
3
1

i

-
o
n
a
r
y
p
o
r
h
t
y
r
e
-
D
-
ß
-
y
x
o
e
d
a
r
t
e
t

,

,

,

,

,

,

,

7
6
b
5
a
5
a
3
3
2
-
l
y
h
t
e
-
9
-
)
y
x
o
l
y
s

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
t
c
e
s
n

i

s
a

s
e
s
u

y
l
n
O

B

T
R
A
P

-
)
y
x
o
l
y
s
o
n
a
r
y
p
o
n
n
a
m
-
L
-

-
l
y
h
t
e
m

-

O

,

,

-
i
r
t
-
4
3
2
-
y
x
o
e
d
-
6
(
-
2
-
)
R
b
6
1
S

,

α

,

,

,

i

-
6
4
3
2
-
o
n
m
a
l
y
h
t
e
m
d
-
4
(
-
3
1

i

-
o
n
a
r
y
p
o
r
h
t
y
r
e
-
D
-
ß
-
y
x
o
e
d
a
r
t
e
t

,

,

,

-
a
6
1
R
4
1
S
3
1
S
9
S
b
5
R
a
5
S
a
3
R
2

,

,

,

,

(

7
-
0
6
-
9
2
9
1
3
1

:

o
N

S
A
C

)

A

n
y
s
o
n
p
S
(

i

0
-
3
6
-
9
2
9
1
3
1

)

D

n
y
s
o
n
p
S
(

i

6
3
6

:

o
N

C
A
P
I
C

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

n
o
i
s
u
l
c
n

i

f
o

n
o
i
t
a
r
i
p
x
E

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
1
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

A

T
R
A
P

7
1
0
2

y
r
a
u
n
a
J

1
3

7
0
0
2

y
r
a
u
r
b
e
F

1

g
k
/
g
0
5
8
≥

:

A

n
y
s
o
n
p
S

i

d
a
s
o
n
p
S

i

1
4
1

L 43/18

EN

Official Journal of the European Union

15.2.2007

r
e
t
a
w
d
n
u
o
r
g

r
o
f

l
a
i
t
n
e
t
o
p

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

t
s
u
m

-
b
a
t
e
m

s
t
i

d
n
a

e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

e
h
t

f
o

y
l
r
a
l
u
c
i
t
r
a
p

,

i

n
o
i
t
a
n
m
a
t
n
o
c

e
h
t

n
e
h
w

,

4
0
7
2
2
3

A
G
C

d
n
a

6
0
4
1
0
5

N
Y
S

,

2
0
6
9
5
4

A
O
N

r
o
/
d
n
a

l
i

o
s

e
l
b
a
r
e
n
u
v

l

h
t
i

w

s
n
o
i
g
e
r

n

i

d
e
i
l

p
p
a

s
i

e
c
n
a
t
s
b
u
s

s
e
t
i
l

o

e
v
i
t
c
a

,
s
n
o
i
t
i
d
n
o
c

c
i
t
a
m

i
l
c

,
s

m

s
i
n
a
g
r
o

c
i
t
a
u
q
a

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

t
s
u
m

-
r
e
h

l
l
a
m

s

o
t

k
s
i
r

m
r
e
t
-
g
n
o

l

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

t
s
u
m

.
t
n
e
m
t
a
e
r
t

d
e
e
s

r
o
f

d
e
s
u

s
i

e
c
n
a
t
s
b
u
s

e
h
t

f
i

s
l
a
m
n
a

i

s
u
o
r
o
v
i
b

—

—

—

e
h
t

,
I

V

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p

m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,

m
a
x
o
h
t
e
m
a
i
h
t

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

6
0
0
2

y
l
u
J

4
1

n
o

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

.
t
n
u
o
c
c
a

:
s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

B

T
R
A
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
t
c
e
s
n

i

s
a

s
e
s
u

y
l
n
O

-

N
-
e
n
e
d

i
l
y
-
4
-
n
a
n
i
z
a
i
d
a
x
o
]
5
3
1
[

,

,

i

e
n
m
a
o
r
t
i
n

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

n
o
i
s
u
l
c
n

i

f
o

n
o
i
t
a
r
i
p
x
E

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
1
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

A

T
R
A
P

7
1
0
2

y
r
a
u
n
a
J

1
3

7
0
0
2

y
r
a
u
r
b
e
F

1

g
k
/
g
0
8
9
≥

-
5
-
l
o
z
a
i
h
t
-
o
r
o
h
c
-
2
(
-
3
-
)
Z
E
(

l

,

-
l
y
h
t
e
m
-
5
-
)
l
y
h
t
e
m
l
y

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

4
-
3
2
-
9
1
7
3
5
1

:

o
N

S
A
C

7
3
6

:

o
N

C
A
P
I
C

m
a
x
o
h
t
e
m
a
i
h
T

2
4
1

-
o
r
p
p
a

e
r
e
h
w

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

’

.
e
t
a
i
r
p

.
t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

n

i

d
e
d
i
v
o
r
p

e
r
a

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

f
o

n
o
i
t
a
c
i
f
i
c
e
p
s

d
n
a

y
t
i
t
n
e
d

i

n
o

s
l
i
a
t
e
d

r
e
h
t
r
u
F

)
1
(